Vivo Capital, LLC Top Holdings and 13F Report (2026) About Vivo Capital, LLCInvestment ActivityVivo Capital, LLC has $908.71 million in total holdings as of September 30, 2026.Vivo Capital, LLC owns shares of 50 different stocks, but just 22 companies or ETFs make up 80% of its holdings.Approximately 14.93% of the portfolio was purchased this quarter.About 16.38% of the portfolio was sold this quarter.This quarter, Vivo Capital, LLC has purchased 47 new stocks and bought additional shares in 5 stocks.Vivo Capital, LLC sold shares of 8 stocks and completely divested from 5 stocks this quarter.Largest Holdings Praxis Precision Medicines $78,957,113Trevi Therapeutics $60,569,061Erasca $58,942,275Arrivent BioPharma Inc $54,113,509Abivax SA $41,083,299 Largest New Holdings this Quarter M40527109 - Entera Bio $35,661,762 Holding23255M303 - Korsana Biosciences Inc $28,064,640 Holding095130100 - Blossomhill Therapeutics Inc $27,843,314 Holding929033207 - Vor Biopharma Inc $10,500,831 Holding22978P205 - Cue Biopharma Inc $7,245,075 Holding Largest Purchases this Quarter Entera Bio 12,254,901 shares (about $35.66M)Korsana Biosciences Inc 877,020 shares (about $28.06M)Blossomhill Therapeutics Inc 1,493,740 shares (about $27.84M)Vor Biopharma Inc 550,358 shares (about $10.50M)Cue Biopharma Inc 280,057 shares (about $7.25M) Largest Sales this Quarter Dyne Therapeutics Inc 1,043,064 shares (about $16.80M)Oric Pharmaceuticals 924,394 shares (about $12.45M)Trevi Therapeutics 864,985 shares (about $12.39M)Bright Minds Biosciences Inc 139,293 shares (about $6.94M)Compass Therapeutics 4,333,513 shares (about $4.51M) Sector Allocation Over TimeMap of 500 Largest Holdings ofVivo Capital, LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorPraxis Precision Medicines$78,957,1130.0%271,1168.7%CommonTRVITrevi Therapeutics$60,569,061$12,386,585 ▼-17.0%4,229,6836.7%HealthcareERASErasca$58,942,275$1,565,585 ▼-2.6%4,020,6196.5%HealthcareArrivent BioPharma Inc$54,113,509$3,179,612 ▲6.2%1,787,1046.0%CommonAbivax SA$41,083,2990.0%414,8994.5%SPONSORED ADSENTXEntera Bio$35,661,762$35,661,762 ▲New Holding12,254,9013.9%HealthcareACRSAclaris Therapeutics$35,213,7910.0%6,694,6373.9%HealthcareAlto Neuroscience Inc$34,718,630$3,856,485 ▲12.5%1,359,9153.8%CommonTNGXTango Therapeutics$34,425,2370.0%1,379,7693.8%HealthcareCRVSCorvus Pharmaceuticals$32,323,0000.0%2,805,8163.6%HealthcareLB Pharmaceuticals Inc$30,704,0000.0%800,0003.4%CommonKorsana Biosciences Inc$28,064,640$28,064,640 ▲New Holding877,0203.1%CommonBlossomhill Therapeutics Inc$27,843,314$27,843,314 ▲New Holding1,493,7403.1%CommonFaeth Therapeutics Inc$25,117,690$3,644,815 ▲17.0%844,5762.8%CommonCAMP4 Therapeutics Corporation$22,559,808$5,403,674 ▲31.5%5,584,1112.5%CommonACHVAchieve Life Sciences$22,255,8490.0%2,751,0322.4%HealthcareSAB Biotherapeutics Inc$21,920,585$1,220,127 ▼-5.3%6,915,0112.4%CommonDBV Technologies SA$21,694,3540.0%1,844,7582.4%SPONSORED ADSBright Minds Biosciences Inc$20,818,732$6,939,577 ▼-25.0%417,8792.3%CommonDSGNDesign Therapeutics$20,274,1910.0%1,612,9032.2%HealthcareAN2 Therapeutics Inc$16,777,3650.0%3,153,6401.8%CommonMLTXMoonLake Immunotherapeutics$16,380,0000.0%1,400,0001.8%HealthcareNERVMinerva Neurosciences$14,481,2020.0%4,322,7471.6%HealthcareOdyssey Therapeutics Inc$12,776,5000.0%575,0001.4%CommonORICOric Pharmaceuticals$12,451,560$12,451,587 ▼-50.0%924,3921.4%HealthcareEupraxia Pharmaceuticals Inc$12,285,0000.0%1,350,0001.4%CommonVor Biopharma Inc$10,500,831$10,500,831 ▲New Holding550,3581.2%CommonEDITEditas Medicine$9,136,9930.0%3,555,2501.0%HealthcareSurrozen Inc$8,366,8000.0%260,0000.9%CommonDyne Therapeutics Inc$8,287,016$16,803,761 ▼-67.0%514,4020.9%CommonAURAAura Biosciences$7,326,6690.0%1,166,6670.8%HealthcareCue Biopharma Inc$7,245,075$7,245,075 ▲New Holding280,0570.8%CommonMonopar Therapeutics Inc$7,210,1350.0%90,5000.8%CommonSatellos Bioscience Inc$6,916,1610.0%813,6660.8%CommonOLMAOlema Pharmaceuticals$5,804,7240.0%671,8430.6%HealthcarePEPGPepGen$5,626,5000.0%2,325,0000.6%HealthcareOnkure Therapeutics Inc$5,253,0100.0%1,927,7100.6%CommonAttovia Therapeutics Inc$5,142,000$5,142,000 ▲New Holding300,0000.6%CommonADARx Pharmaceuticals Inc$5,087,851$5,087,851 ▲New Holding255,1580.6%CommonTenax Therapeutics Inc$4,725,0000.0%2,500,0000.5%CommonVALNValneva$4,720,3860.0%763,1990.5%HealthcareAvalo Therapeutics Inc$4,215,7500.0%275,0000.5%CommonCMPXCompass Therapeutics$3,560,489$4,506,854 ▼-55.9%3,423,5470.4%HealthcareSERASera Prognostics$3,449,4200.0%1,650,4400.4%HealthcareInstil Bio Inc$2,119,4590.0%292,7430.2%CommonInMed Pharmaceuticals Inc$1,121,829$36,036 ▲3.3%824,8740.1%CommonBolt Biotherapeutics Inc$266,4840.0%72,4140.0%CommonPasithea Therapeutics Corp$183,788$45,689 ▼-19.9%372,7960.0%CommonPrecision Biosciences Inc$29,2660.0%4,6750.0%CommonJasper Therapeutics Inc$3,693$3,693 ▲New Holding5,3640.0%CommonSVASinovac Biotech$0$38,192,410 ▼-100.0%00.0%HealthcareDianthus Therapeutics Inc$0$34,507,725 ▼-100.0%00.0%CommonGERNGeron$0$11,099,900 ▼-100.0%00.0%HealthcareALXOALX Oncology$0$6,592,356 ▼-100.0%00.0%HealthcareUnicycive Therapeutics$0$2,579,500 ▼-100.0%00.0%CommonShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.